Gattefossé

Abstract Pharmaceutical excipients such as P-glycoprotein inhibitors can also increase the solubility and affinity of drugs to the intestinal membrane,...

Abstract Purpose: To improve the oral absorption of relugolix (RLGL), which has low oral bioavailability due to its low solubility...

Abstract Background: The emphasis on the use of surfactants in enhancing drug release from fatty suppository bases has always been...

Abstract In response to recent regulatory guidelines, including ICH (International Council for Harmonisation) Q2 (R2) and Q14, we developed a...

Discover the interview given by Alexandre Gil, Gattefossé Group Director for Pharmaceuticals, in Pharma Industrial India. In this interview, he...

Abstract Colorectal cancer (CRC) is characterized by abnormal cell growth in the colon and rectum, leading to cancer. Conventional treatments...

Abstract Background/Objectives: Following tooth extraction, resveratrol (RSV) can support healing by reducing inflammation and microbial risks, though its poor solubility...

Abstract Psoriasis, a chronic inflammatory skin disease, poses a significant burden on patients’ quality of life and healthcare systems. While...

Abstract The continuous synthesis of nanoparticles (NPs) has been actively studied due to its great potential to produce NPs with...

Abstract Multiparticulate drug delivery systems offer advantages in controlled release, dose flexibility, and personalized medicine. Fusion prilling, a process that...